Target of rapamycin (TOR) is a highly conserved serine/threonine kinase that controls cell
growth, primarily via regulation of protein synthesis. In Saccharomyces cerevisiae, TOR can …

Tor proteins, targets of the antiinflammatory drug rapamycin, mediate a conserved signaling
pathway required for cell growth and proliferation in eukaryotes. By global transcriptional …

Target of rapamycin (TOR) is a conserved regulator of gene expression from yeast to
humans. In budding yeast, TOR is associated with ribosomal DNA (rDNA) promoter, which is …

Target of rapamycin (TOR) is a central component of the eukaryotic growth regulatory
network. TOR controls the expression of diverse genes by all three RNA polymerases …

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that plays an
essential role in cell growth control. mTOR stimulates cell growth by phosphorylating p70 …

Mammalian target of rapamycin (mTOR) and phosphatidylinositol 3-kinase (PI3K) regulate
cell growth, protein synthesis, and apoptosis in response to nutrients and mitogens. As an …

The mammalian target of rapamycin (mTOR) has attracted growing attention during the past
decade due to the increase realization of it's extraordinarily significance in cellular …

The mammalian target of rapamycin (mTOR) controls multiple cellular functions in response
to amino acids and growth factors, in part by regulating the phosphorylation of p70 S6 …

In Saccharomyces cerevisiae, the Tap42–phosphatase complexes are major targets of the
Tor kinases in the rapamycin‐sensitive signaling pathway. The immunosuppressive agent …

Tuberous sclerosis complex 2 (TSC2) and phosphatase and tensin homolog deleted on
chromosome 10 (PTEN) function to block growth factor-induced mammalian target of …